February 2022: Peru Update

The Peruvian Registry of Clinical Trials (REPEC) published a notification (PRESS RELEASE No. 006-2022-OGITT/INS) on February 03, 2022, stating that-

The services of REPEC Version 2 (V2) have been restored. All the documentation entered through [email protected] during the month of January to date must be regularized in the REPEC V2 in order to have the updated information of the clinical trials presented.